Evidence map›Paper›PMID 26332194›Full record

ArticleNMR in biomedicine2015

Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.

Stephanie L Barnes, Anna G Sorace, Mary E Loveless, Jennifer G Whisenant, Thomas E Yankeelov

Abstract readComparative StudyValidation Study
In one paragraph

Article in NMR in biomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Dynamic image-informed selection of biomechanical tumor growth models.Biomechanics and modeling in mechanobiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Towards integration ofScientific reports · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie L BarnesVanderbilt Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA.
Anna G SoraceVanderbilt Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA.
Mary E LovelessVanderbilt Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA.
Jennifer G WhisenantVanderbilt Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA.
Thomas E YankeelovVanderbilt Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA.
Vanderbilt Health · USVanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
TISSUE CoreP50CA098131 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PARK, BEN HO, PIETENPOL, JENNIFER A · 2003 to 2024
$48.7M
Multidisciplinary Training in Basic and Translational Imaging of CancerR25CA092043 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MANNING, HENRY CHARLES · 2001 to 2015
$6.6M
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast CancerU01CA174706 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO, YANKEELOV, THOMAS E · 2013 to 2018
$2.5M
Training Grant In Radiation BiologyT32CA093240 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREEMAN, MICHAEL L. · 2002 to 2016
$2.3M
Evaluation and Validation of Imaging Biomarkers of Tumor Response to TreatmentR01CA138599 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MCINTYRE, JAMES OLIVER · 2010 to 2015
$2.2M
NCI NIH HHS 5T32 CA093240NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCI NIH HHS P50 CA098131NCI NIH HHS R01 CA138599NCI NIH HHS R25 CA092043NCI NIH HHS T32 CA093240NCI NIH HHS U01 CA174706
6 · The paper itself

Abstract

The purpose of this work was to determine the relationship between the apparent diffusion coefficient (ADC, from diffusion-weighted (DW) MRI), the extravascular, extracellular volume fraction (ve , from dynamic contrast-enhanced (DCE) MRI), and histological measurement of the extracellular space fraction. Athymic nude mice were injected with either human epidermal growth factor receptor 2 positive (HER2+) BT474 (n = 15) or triple negative MDA-MB-231 (n = 20) breast cancer cells, treated with either Herceptin (n = 8), Abraxane (low dose n = 7, high dose n = 6), or saline (n = 7 for each cell line), and imaged using DW- and DCE-MRI before, during, and after treatment. After the final imaging acquisition, the tissue was resected and evaluated by histological analysis. H&E-stained central slices were scanned using a digital brightfield microscope and evaluated with thresholding techniques to calculate the extracellular space. For both BT474 and MDA-MB-231, the median ADC of the central slice exhibited a significantly positive correlation with the corresponding central slice extracellular space as measured by H&E (p = 0.03, p < 0.01, respectively). Median ve calculated from the central slice showed differing results between the two cell lines. For BT474, a significant correlation between ve and extracellular space was calculated (p = 0.02), while MDA-MB-231 tumors did not demonstrate a significant correlation (p = 0.64). Additionally, there was no correlation discovered between ADC and ve with either whole tumor analysis or central slice analysis (p > 0.05). While ADC correlates well with the histologically determined fraction of extracellular space, these data add to the growing body of literature that suggests that ve derived from DCE-MRI is not a reliable biomarker of extracellular space for a range of physiological conditions.

Indexed as

Albumin-Bound PaclitaxelAnimalsAntineoplastic AgentsBreast NeoplasmsCarcinomaCell Line, TumorContrast MediaDiffusionDiffusion Magnetic Resonance ImagingErb-b2 Receptor Tyrosine KinasesFemaleGadolinium DTPAHeterograftsHumansMagnetic Resonance ImagingMiceAlbumin-Bound PaclitaxelAntineoplastic AgentsContrast MediaERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesGadolinium DTPATrastuzumabapparent diffusion coefficientextracellular spaceextravascular extracellular spacequantitative imaging

Identifiers

PMID26332194
PMCPMC4573954
OpenAlexW1828047435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.